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Impact of intrathecal morphine analgesia
on the incidence of pulmonary
complications after cardiac surgery: a single
center propensity-matched cohort study
Christoph Ellenberger1, Tornike Sologashvili2, Krishnan Bhaskaran3 and Marc Licker1*
Abstract
Background: Acute pain and systemic opioids may both negatively impact respiratory function after cardiac surgery.
This study analyzes the local practice of using intrathecal morphine analgesia (ITMA) with minimal parenteral opioid
administration in cardiac surgery, specifically the impact on postoperative pulmonary complications (PPCs).
Methods: Data from adult patients who underwent elective cardiac surgery between January 2002, and December 2013
in a single center were analyzed. Propensity scores estimating the likelihood of receiving ITMA were used to match (1:1)
patients with ITMA and patients with intravenous analgesia (IVA). Primary outcome was PPCs, a composite endpoint
including pneumonia, adult respiratory distress syndrome, and any type of acute respiratory failure. Secondary outcomes
were in-hospital mortality, cardiovascular complications, and length of stay in the intensive care unit (ICU) and hospital.
Results: From a total of 1′543 patients, 920 were treated with ITMA and 623 with IVA. No adverse event consequent to
the spinal puncture was reported. Propensity score matching created 557 balanced pairs. The occurrence of PPCs in
patients with ITMA was 8.1% vs. 12.8% in patients with IVA (odds ratio, 0.6; 95% CI, 0.40–0.89; p = 0.012). Fewer patients
with ITMA had a prolonged stay in the ICU (> 4 days; 16.5% vs. 21.2%, p = 0.047) or in the hospital (> 15 days; 25.5% vs.
31.8%. p = 0.024). In-hospital mortality and cardiovascular complications did not differ significantly between the two
groups.
Conclusion: In this study involving cardiac surgical patients, ITMA was safely applied and was associated with fewer
PPCs.
Keywords: Spinal analgesia, Postoperative respiratory failure, Opiates, Pulmonary complications
Background
Postoperative pulmonary complications (PPCs) such as
pneumonias and acute respiratory failure are important
contributors to major morbidity and mortality, prolonged
hospital stay and reduced long-term survival following
major surgical procedures [1]. Patients undergoing open
heart surgery are at high risk of PPCs [2–4]. In the
immediate postoperative period, vital capacity and func-
tional residual capacity are decreased by approximately 30
to 60% and progressively recover over the next 10 to
15 days [5, 6]. This reduction in pulmonary volumes is
strongly related to the degree of pain that prevents the pa-
tient to cough adequately and to take deep breaths in
order to clear the airways and to reopen collapsed alveolar
areas [7–9].
Currently, pain management in cardiac surgery is
largely based on systemic opioids, combined with non-
steroidal anti-inflammatory drugs and paracetamol.
However, opiate-based analgesia produces dose-related
adverse events such as respiratory depression, nausea/
vomiting, constipation, pruritus and mental confusion,
which all may impair functional recovery and delay
patient discharge from the hospital. [10] In addition,
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opioid-induced hyperalgesia may occur when large intra-
venous doses are given intraoperatively [11].
A possible way to provide efficient analgesia with
minimal systemic opioid administration is the intra-
thecal administration of a small dose of morphine
(“spinal analgesia”) [12, 13]. Analgesia starting 30 min
and lasting up to 24 h has been reported after single-
shot injection as a result of direct activation of the μ
opioid receptors in the substantia gelatinosa of the
posterior spinal cord, with no interference with blood
pressure and heart rate control. [12]
To facilitate postoperative awakening and extubation
while improving postoperative pain control, intrathecal
morphine analgesia (ITMA) with minimal systemic
opioid administration has been implemented in cardiac
surgery at our institution since 2002. In the current
study, we have questioned the safety and the clinical
impact of ITMA in our local cohort of cardiac surgical
patients. Therefore, based on administrative and clinical
hospital data, we have analyzed the relationship between
the type of intraoperative analgesic regimen and the
occurrence of major adverse events, particularly the
incidence of PPCs.
Methods
Patient population and data collection
The study was approved by the local ethic committee
(CER file number: 14-080R) with a waiver of the require-
ment for obtaining written informed consent. We col-
lected data concerning all patients undergoing elective
cardiac surgery between January 1, 2002 and December
31, 2013. The patients were identified in the hospital
electronic charting system by searching for the Swiss
classification of surgical interventions (CHOP) code for
cardiopulmonary bypass (CPB). Emergent cases, patients
hospitalized in the intensive care unit (ICU) before
surgery, and those scheduled for implantation of a
ventricular assist device were excluded from the study.
Also patients requiring redo surgery (e.g., for bleeding or
cardiac tamponade) were excluded from the analysis, be-
cause spinal analgesia was not repeated and all patients
treated with intravenous opioids. If a patient underwent
more than one cardiac surgery during the study period,
only the first procedure was included in the analysis.
A data set was created containing all World Health
Organization International Classification of Diseases
codes (ICD-10), and all CHOP codes related to the pa-
tient’s hospital stay, as well as demographic data (age,
sex), length of hospital stay, length of stay in the ICU,
and the date of death. Information regarding the type of
the analgesia technique (ITMA or standard intravenous
analgesia (IVA)) was collected by scanning anesthesia
worksheets (from January 1st, 2002 to December 31,
2006) or from the electronic anesthesia records (from
January 1st, 2007 to December 31, 2013). ICD-10 codes
were used for classification of the co-morbidities based
on the methodology of Quan et al. [14] (Additional file
1: Annex A). The type of surgery was stratified into 4
categories based on the CHOP codes: coronary artery
bypass grafting, valve surgery, combined surgery, and
other surgery (e.g. surgery of the ascending aorta or
adult congenital heart surgery).
Postoperative ICU data regarding the duration of
mechanical ventilation, the need for non-invasive venti-
lation (NIV) and/or continuous positive airway pressure
(CPAP) therapy, as well as the daily administration of
morphine and fentanyl and pain scores were extracted
from the electronic ICU records. Due to the launching
date of the advanced information system for the ICU
(Clinisoft) only data from patients operated after 2006
were available.
Perioperative analgesia
ITMA was proposed to all patients in the absence of
hemostatic disorders, abnormal coagulation tests, or an-
tiplatelet therapy other than aspirin. If a patient accepted
ITMA, intraoperative analgesia consisted in an intra-
thecal single-shot injection of 10 mcg/kg morphine in
the lumbar space (L3-L4) using a 25-gauge spinal needle
prior to induction of general anesthesia, whereas sys-
temic administration of opioids was limited to the time
of anesthesia induction, skin incision and sternotomy
(sufentanyl 15–25 mcg or fentanyl 150–250 mcg). In the
IVA group (patients refusing ITMA or patients with a
contraindication for ITMA), intravenous opiates were
administered as a bolus during anesthesia induction
(sufentanyl 10–20 mcg or fentanyl 100–200 mcg) and
before skin incision sufentanyl 10–20 mcg or fentanyl
100–200 mcg), and continuously thereafter until skin
closure (sufentanyl 10–25 mcg/h or fentanyl 100–250
mcg/h).
Perioperative management
Standard monitoring included an arterial line, a central
venous catheter, transesophageal echocardiography (TEE)
and bispectral analysis of the electroencephalographic
signals (BIS). After anesthesia induction and orotracheal
intubation, patients were mechanically ventilated using
tidal volumes of 6–8 ml.kg−1 of predicted body weight, a
positive end-expiratory pressure of 5–10 cm of water and
regular recruitment maneuvers (at least once an hour).
Anesthesia was maintained with propofol to target BIS
values 40–60. To enhance myocardial protection (precon-
ditioning) sevoflurane 1–1.5 MAC was administrated for
at least 30 min in the prebypass period [15].
Cardiac surgery was performed via full sternotomy.
The circuit of the nonpulsatile CBP machine was primed
with 1 L of crystalloids and 1 L of hydroxyethyl starch
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6% 130/0.4. Myocardial protection was achieved by ante-
grade infusion of hyperkaliemic cold blood. Following
aortic cross-clamping, the lungs were disconnected from
the ventilator. All patients received an intravenous bolus
of 15 mg·kg−1 tranexamic acid with an additional dose of
10 mg·kg−1 in the CPB priming fluid. Weaning from the
CPB was guided by TEE assessment and invasive pres-
sure monitoring [16]. Besides titration of fluids, cardio-
vascular medications were given to target specific
hemodynamic endpoints: LV end-diastolic diameter (up
to preoperative values, respectively 2.2 to 2.8 cm/m2),
mean arterial pressure (MAP) between 65 and 90 mmHg
and HR between 70 and 100 beats/min.
Study endpoints
The primary outcome was PPCs, a composite endpoint of
the occurrence of pneumonia (with the exception of viral
pneumonia), adult respiratory distress syndrome (ARDS)
and any other cause of acute respiratory failure during
hospitalization. ICD-10 codes were used to retrieve
pneumonia, ARDS and acute respiratory failure
(Additional file 1: Annex A). Postoperative atelectasis was
not included in the primary outcome as its identification
could be dependent on subjective evaluation by the clin-
ician in charge of the patients. Secondary outcomes were
in-hospital mortality at 60 days, cardiovascular adverse
events including acute myocardial infarction, stroke, and
the need for intra-aortic balloon pump as a sign of postop-
erative heart failure, as well as the length of stay in the
ICU and hospital. We further searched the database for
any neurological complication related to ITMA.
In patients operated later than 2006 we analyzed the
duration of mechanical ventilation and the need for NIV
and CPAP in the two groups. We also compared the
number of patients receiving morphine and fentanyl par-
enterally, the total dose administered, and the postopera-
tive pain scores within the first two days after surgery.
Analysis
The computer software Stata 14 (Stata Corp, College
Station, TX, USA) was used for statistical analysis. Pro-
pensity score matching was used to reduce confounding,
respectively to adjust for baseline differences between
the two groups. A non-parsimonious logistic regression
model was constructed estimating the likelihood that
any given individual in the cohort would be in the ITMA
group, given the set of baseline variables. The following
variables were included in the model: age, gender, type
of surgery, as well as the following comorbidities:
diabetes, high blood pressure, hypercholesterolemia, cor-
onary heart disease, peripheral vascular disease, chronic
pulmonary disease, smoking, obesity, and chronic kidney
disease. The functional form of the regression equation
was assessed with the Hosmer-Lemeshow test showing a
good fit (p = 0.394), therefore no interaction terms were
included in the model.
Patients with ITMA were then individually matched
(1:1) with patients with IVA based on the similarity of
the propensity score [17]. A nearest neighbor matching
technique without replacement was carried out using
the Stata ‘psmatch2’ module [18]. Caliper distance was
set at 0.1 standard deviations of the sample estimated
propensity scores because larger calipers (0.20 or 0.25
standard deviations) were unable to balance the cohorts
[17]. The ability of the model to balance the cohorts was
assessed using standardized differences. Differences of
absolute value less than 10% were considered to indicate
well balanced covariates [19]. Because ICU data were
only available in patients operated later than 2006, we
stratified the analysis into two periods (2002–2006 and
2007–2013) to avoid the creation of matched pairs with
missing data. Conditional logistic regression was used to
compare categorical outcomes in the matched dataset,
Wilcoxon signed-rank tests were used to compare quan-
titative outcomes.
Sensitivity analyses
Overall patient management may have changed/im-
proved over the study period. To evaluate this potential
source of confounding, a post hoc sensitivity analysis
was carried out to assess the effect of ITMA on PPCs
after balancing the year of surgery in the two groups.
The presence of hemostatic disorders could represent
another source of confounding, since these disorders are
contraindications for ITMA and are potentially associ-
ated with worse outcome due to increased postoperative
bleeding. Because it was not possible to identify
hemostatic disorders reliably in the electronic charting
system, an estimator of postoperative bleeding was
created, based on the codes for post-procedural
hemorrhage, acute post-hemorrhagic anemia, and hypo-
volemic shock. A second post-hoc sensitivity analysis was
then carried out to assess the effect of ITMA on PPCs
after balancing postoperative bleeding in the two groups.
For the sensitivity analyses the same statistical model
was used, with the exception that the year of surgery,
respectively postoperative bleeding, was included.
Results
Patient enrolment is shown in Fig. 1. Overall, 1′543
patients were analyzed, 920 (59.6%) with ITMA and 623
(40.4%) with IVA. Baseline characteristics are shown in
Table 1. Before matching, patients in the IVA group
were slightly older and more likely to have risk factors
for coronary heart disease including diabetes, dyslipid-
emia, smoking, and hypertension. They also underwent
more often coronary artery bypass graft (CABG) surgery.
The algorithm provided 557 pairs of ITMA/IVA patients.
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Fig. 1 Patient enrolment
Table 1 Patient characteristics before and after propensity score matching
Patient characteristics Patients
with IVA
Patients
with ITMA
Standardized
difference
Patients
with IVA
Patients
with ITMA
Standardized
difference
N = 623 N = 920 % N = 557 N = 557 %
Age (years) a 65.1 (15.3) 61.4 (17.2) −22.8 64.7 (15.7) 63.8 (16.0) −5.1
Sex (male) 424 (68.1) 610 (66.3) 3.7 372 (66.8) 381 (68.4) 3.4
Hypertension 344 (55.2) 432 (47.0) −16.6 295 (52.3) 288 (51.7) −2.5
Diabetes 134 (21.5) 159 (17.3) −10.7 112 (20.1) 113 (20.3) 0.5
Hypercholesterolemia 137 (22.0) 180 (19.6) −6.0 116 (20.8) 125 (22.4) 4.0
Coronary heart disease 331 (53.1) 335 (36.4) −34.1 269 (48.3) 263 (47.2) −2.2
Peripheral vascular disease 127 (20.4) 171 (18.6) −4.5 108 (19.4) 120 (21.5) 5.4
Chronic pulmonary disease 63 (10.1) 77 (8.4) −6.0 46 (8.3) 48 (8.6) 1.2
Smoking 102 (16.4) 87 (9.5) −20.7 65 (11.7) 62 (11.1) −1.6
Obesity 57 (9.2) 82 (8.9) −0.8 51 (9.2) 56 (10.1) 3.1
Chronic kidney disease 79 (12.7) 79 (8.6) −13.3 63 (11.3) 55 (9.9) −4.7
Parsonnet score 14.9 (9.0) 13.7 (8.7) −13.4 14.7 (9.0) 14.7 (9.1) 0.5
Type of surgery
CABG 187 (30.0) 182 (19.8) −23.8 151 (27.1) 136 (24.4) −6.3
Valve surgery 291 (46.7) 530 (57.6) 21.9 281 (50.5) 283 (50.8) 0.7
Combined surgery 110 (17.7) 123 (13.4) −11.9 91 (16.3) 94 (16.9) 1.5
Other 35 (5.6) 85 (9.2) 13.8 34 (6.1) 44 (7.9) 6.9
Data given as number (percentage) unless otherwise indicated
IVA intravenous analgesia; ITMA intrathecal morphine analgesia; CABG coronary artery bypass graft
a Data given as mean (standard deviation)
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The matching process achieved a good balance for all
comorbidities and the type of surgery.
The primary and secondary study outcomes are
summarized in Table 2. In the whole cohort of 1′543
patients, PPCs occurred in 167 patients (9.0% in the
ITMA group vs. 13.5% in the IVA group, p = 0.006),
and 63 patients died within the first 60 days after
surgery (3.2% in the ITMA group vs. 5.5% in the IVA
group, p = 0.025). In the propensity matched cohort,
the proportion of patients with PPCs in patients with
ITMA was 8.1% compared to 12.8% in patients with
IVA (odds ratio, 0.6; 95% CI, 0.40–0.89; p = 0.012).
All three clinical outcomes of the composite endpoint
occurred less frequently in the ITMA group. Overall,
pneumonia and acute respiratory failure were the
most frequent adverse events.
The proportion of patients with prolonged ICU stay
(longer than 4 days) was significantly lower in patients
with ITMA (16.5% vs. 21.2%; OR 0.73, 95%CI 0.54–0.99,
p = 0.047). Likewise, the proportion of patients staying
longer than 15 days in the hospital was also lower in the
ITMA group (26.9% vs. 31.6%; OR 0.74, 95%CI 0.57–
0.96, p = 0.024). Mortality at 60 days, the need for intra-
aortic balloon pump and the occurrence of stroke did
not differ significantly between the two groups. There
were no neurological complications or spinal hematomas
related to the spinal puncture in patients with ITMA.
The ICU data of patients operated later than 2006 are
shown in Table 3. The duration of mechanical ventilation
as well as the administration of CPAP and NIV were simi-
lar in both groups. During the first 24 h, the median pain
score (on a scale of 0 to 10) was significantly lower in the
ITMA group (1.8 [0.0–3.2] vs. 3.0 [1.3–4.0, p < 0.001) and
fewer patients experienced a pain score ≥ 5 (7.2% vs.
15.1%; OR 0.45, 95%CI 0.26–0.78, p = 0.004). Fewer pa-
tients in the ITMA group were treated with morphine
during the first 24 h (61.0% vs. 74.6%; OR 0.55 95%CI
0.40–0.76, p < 0.001) and the median dose per treated
patient was significantly lower (8 mg [4–14] vs.
15 mg [8–24], p < 0.001). Likewise, fewer patients in
the ITMA group were treated with fentanyl (26.6% vs
33%, OR 0.69, 95%CI 0.51–1.00, p = 0.052) with a
median dose that was significantly lower (150 mcg
[73–390] vs. 276 mcg [125–601], p = 0.002).
Sensitivity analyses
The first sensitivity analysis was carried out to assess
potential confounding related to changes in patient
management over time. The propensity score–matching
algorithm created 514 patient pairs who were well bal-
anced for all baseline characteristics, including the year
of surgery. The effect on the association between anal-
gesia regimen and PPC was minimal and the occurrence
of PPCs in patients with ITMA remained significantly
Table 2 Patient outcomes before and after propensity score matching
Entire sample Propensity Matched Cohort
Outcomes IVA ITMA IVA ITMA OR
(95% CI)
P-
ValueN = 623 N = 920 N = 557 N = 557
Respiratory complications 84 (13.5) 83 (9.0) 71 (12.8) 45 (8.1) 0.60 (0.40–0.89) 0.012
Acute respiratory insufficiency 49 (7.9) 47 (5.1) 45 (8.1) 22 (4.0) 0.45 (0.21–0.98) 0.047
Pneumonia 52 (8.4) 43 (4.7) 43 (7.7) 27 (4.9) 0.60 (0.36–0.99) 0.048
ARDS 5 (0.8) 3 (0.3) 5 (0.8) 0 (0.0) NA NA
Secondary outcomes
Death (60d post-op) 34 (5.5) 29 (3.2) 33 (5.9) 22 (4.0) 0.66 (0.38–1.14) 0.134
Myocardial infarction 61 (9.8) 48 (5.2) 49 (8.8) 33 (5.9) 0.66 (0.42–1.04) 0.072
Stroke 25 (4.0) 31 (3.7) 20 (3.6) 24 (4.3) 1.22 (0.66–2.28) 0.528
IABP 18 (2.9) 29 (3.2) 18 (2.9) 19 (3.4) 1.06 (0.54–2.10) 0.862
Postoperative Bleeding a 63 (10.1) 66 (7.2) 56 (10.1) 41 (7.4) 0.71 (0.46–1.08) 0.111
ICU stay, days b 2 (1–4) 2 (1–3) 2 (1–4) 2 (1–3) 0.014 c
ICU stay >4 days 135 (21.7) 146 (15.9) 118 (21.2) 92 (16.5) 0.73 (0.54–0.99) 0.047
Hospital stay days b 13 (10–17) 12 (9–16) 13 (10–17) 12 (9–16) 0.038 c
Hospital stay >15 days 197 (31.6) 247 (26.9) 177 (31.8) 142 (25.5) 0.74 (0.57–0.96) 0.024
Data given as number (percentage) unless otherwise indicated. Conditional logistic regression was used for statistical tests in the matched cohort unless
otherwise indicated
IVA intravenous analgesia; ITMA intrathecal morphine analgesia; ARDS adult respiratory distress syndrome; IABP intra-aortic balloon pump; ICU intensive care unit
a Composite of post-procedural hemorrhage, acute post-hemorrhagic anemia, and hypovolemic choc
b Data given as median (interquartile range)
c Wilcoxon signed-rank test
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lower compared with the IVA (odds ratio, 0.65; 95% CI,
0.44–0.95; p = 0.027).
The second sensitivity analysis was carried out to as-
sess potential confounding related to the bleeding risk.
The propensity score–matching algorithm created 561
patient pairs who were well balanced for all baseline
characteristics as well as postoperative bleeding. Balan-
cing postoperative bleeding in the two groups had only a
small effect, and ITMA remained associated with lesser
risk of PPCs (odds ratio, 0.66; 95% CI, 0.49–0.96;
p = 0.030).
Discussion
In this single center cohort study, the use of ITMA in
elective cardiac surgery, together with restrictive paren-
teral opioid administration, was associated with a lower
incidence of PPCs as defined by the occurrence of
pneumonia, ARDS and other forms of acute respiratory
failure during hospitalization. In addition, ITMA was
also associated with lesser requirements of opioids and
lower pain during the first postoperative day whereas
fewer patients requiring a prolonged ICU and hospital
stay.
Acute postoperative pain is a common problem after
cardiac surgery [20]. Impaired coughing, shallow breath-
ing, immobility and bed rest may lead to atelectasis and
reduced clearance of pulmonary secretions increasing
the risk of atelectasis, pneumonia and respiratory insuffi-
ciency [7, 21]. Deep breathing exercises have been
shown effective in reducing atelectatic areas and improv-
ing pulmonary function in patients undergoing CABG
surgery [22]. Adequate pain control is therefore essential
and systemic opioids remain the cornerstone of postop-
erative analgesia after cardiac surgery. Unfortunately, the
Table 3 ICU characteristics before and after propensity score matching
Entire sample Propensity Matched Cohort
Outcomes IVA ITMA IVA ITMA OR
(95% CI)
P-Value
N = 355 N = 648 N = 346 N = 346
Respiratory treatment
Mechanical ventilation, min a 505 (275–1001) 458 (206–958) 501 (275–994) 496 (212–997) 0.790 b
CPAP 267 (75.2) 483 (74.5) 260 (75.1) 259 (74.9) 0.99 (0.70–1.38) 0.931
min per patient treated a 125 (75–215) 120 (60–240) 120 (72.5–213) 120 (75–240) 0.385 b
NIV 81 (22.8) 153 (23.6) 79 (22.8) 75 (21.7) 0.94 (0.66–1.33) 0.722
min per patient treated a 120 (60–240) 110 (60–220) 120 (60–240) 155 (60–275) 0.470 b
Opioid administration
Day 1
Morphine 265 (74.7) 400 (61.7) 258 (74.6) 211 (61.0) 0.55 (0.40–0.76) <0.001
mg per patient a 15 (8–24) 8.5 (4–15.5) 15 (8–24) 8.0 (4–16) <0.001 b
Fentanyl 119 (33.5) 165 (26.1) 115 (33.2) 92 (26.6) 0.69 (0.51–1.00) 0.052
mcg per patient a 276 (125–583) 160 (75–400) 276 (125–601) 150 (73–390) 0.002 b
Day 2
Morphine 127 (39.7) 196 (35.1) 123 (39.6) 111 (35.9) 0.86 (0.62–1.17) 0.334
mg per patient a 8.0 (3–13) 8.0 (3–14) 7.0 (3–14) 8.0 (3–13) 0.275 b
Fentanyl 50 (15.6) 86 (15.4) 48 (15.4) 50 (16.2) 1.05 (0.69–1.59) 0.831
mcg per patient a 348 (100–1136) 175 (50–641) 348 (100–1170) 188 (100–545) 0.500 b
Postoperative pain
Day1
Pain score a 2.9 (1.3–4.0) 1.9 (0.0–3.3) 3.0 (1.3–4.0) 1.8 (0.0–3.2) <0.001 b
Pain score ≥ 5 51 (15.0) 50 (8.1) 50 (15.1) 24 (7.2) 0.45 (0.26–0.78) 0.004
Day2
Pain score a 2.4 (1.0–4.0) 2.0 (0.4–3.7) 2.5 (1.0–4.0) 2.0 (0.1–3.8) 0.853 b
Pain score ≥ 5 40 (17.1) 42 (10.7) 39 (17.3) 2753 (12.1) 0.75 (0.38–1.46) 0.400
Data given as number (percentage) unless otherwise indicated. Conditional logistic regression was used for statistical tests in the matched cohort unless
otherwise indicated
IVA intravenous analgesia; ITMA intrathecal morphine analgesia; CPAP continuous positive airway pressure; NIV non-invasive ventilation
a Data given as median (interquartile range)
b Wilcoxon signed-rank test
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use of opioids itself is associated with dose-dependent
adverse drug events including respiratory depression,
dizziness/cognitive dysfunction, nausea/vomiting, consti-
pation, and pruritus [23]. In particular older and sicker
patients are at greater risk for opioid related adverse
events. Therefore, the benefit of parenteral opioids in
this population should be balanced against the risk of
impaired functional recovery and delayed patient
discharge from the hospital. [10]
Central neuraxial analgesia techniques can improve
postoperative pain while reducing the need for systemic
opioids. Conceptually, thoracic epidural analgesia is the
most efficient analgesia technique and has been associ-
ated with a reduction in the incidence of PPCs after
CABG surgery [24]. However, many anesthesiologists are
reluctant to use epidural analgesia in cardiac surgery.
The use of the heart lung machine during cardiac
surgery mandates high levels of blood anticoagulation
increasing the potential risk of puncture related epidural
hematoma/neural trauma [25]. Therefore, ITMA may be
an attractive alternative given its simplicity, high success
rate, and a low risk profile. For these reasons, our car-
diothoracic anesthesia team has adopted this analgesia
technique in the routine perioperative care of cardiac
surgical patients.
To our knowledge, this is the first study assessing the
association between ITMA and PPCs in cardiac surgery.
Previous studies have analyzed the effect of ITMA on
postoperative lung function. In 2 randomized controlled
trials, ITMA was associated with an improved forced vital
capacity (FVC) and forced expiratory volume (FEV) after
cardiac surgery [26, 27]. In contrast, dos Santos et al.
found a similar decline of the FVC and FEV in patients
with ITMA and IVA that was likely attributed to the high
intravenous opiate doses that were given in both groups
[28]. In a cohort of 595 patients undergoing major
vascular surgery, we previously reported that ITMA was
associated with a reduced risk of postoperative morbidity,
particularly PPCs and renal dysfunction [29].
In contrast to most randomized trials, ITMA was not
associated with a shorter duration of postoperative
mechanical ventilation in our patient cohort. [27, 30–34]
A plausible explanation may be the relatively high dose
of intrathecal morphine administered. However, Shroff
et al. found a shorter extubation time when using 10
mcg/kg of intrathecal morphine [34]. In most studies
where ITMA facilitated early extubation, the intrathecal
dose of morphine ranged from 4 to 8 mcg. It has been
recently shown that, in minimal invasive cardiac surgery,
1.5 mcg/kg intrathecal morphine is sufficient to provide
pain control. [35] Consistent with other studies, our
findings confirmed the superior analgesia of intrathecal
morphine that was associated with lower opioid require-
ments in cardiac surgical patients [20].
Two meta-analyses had been conducted to assess the
association between ITMA and postoperative mortality
respectively myocardial infarction. The first by Liu et al.
included 668 patients from 17 randomized trials [24],
the second by Zangrillo et al. included 1106 patients
from 25 randomized trials [36]. Similar to our study, the
authors found no significant association between ITMA
and postoperative mortality (0.3 vs. 0.6%, respectively 0.4
vs. 0.4%) or myocardial infarction (3.9 vs. 5.7%%,
respectively 2.1 vs. 2.7%).
Important limitations need to be discussed when inter-
preting the results of this study. First, this is an observa-
tional study of administrative data using propensity
scores. Propensity scores can only balance for measured
covariates. Therefore, the good balance of covariates in
our matched groups does not indicate balance of un-
measured variables like preoperative medical treatment,
laboratory values, blood transfusion, duration of cardio-
pulmonary bypass/aortic cross-clamping or ventilator
parameters. Furthermore, lung function tests after
cardiac surgery to detect relevant changes in pulmonary
function were not performed on a routine basis. How-
ever, most intraoperative variables are directly related to
patient characteristics and the type of surgery which
were well matched in the two groups. Also, anesthesia
care was highly standardized and protective lung
ventilation strategies were used in all patients. Still, the
possibility that unmeasured variables (e.g., contraindica-
tions for ITMA such as hemostatic disorders) could bias
the effect estimates of ITMA on PPCs needs to be con-
sidered. Conversely, the proportion of postoperative
bleeding was similar in both groups and balancing for
postoperative bleeding had no effect on the association
between ITMA and PPCs. Anticoagulation and anti-
platelet therapy (with the exception of aspirin) were in
general interrupted three to seven days before cardiac
surgery to avoid excessive bleeding.
Second, administrative databases may result in
underreporting of comorbidities and outcome data
[37]. However, this is difficult to assess because clear
definition criteria for PPCs are lacking and the
reported occurrence in the literature is extremely
variable ranging from 8% to 79% [2]. The administra-
tive codes also did not allow precise determination a
major adverse event. For instance, patients with cor-
onary artery disease may first present at the hospital
with signs of a myocardial infarction (and getting a
code for acute myocardial infarction) and then
undergo uneventful elective CABG surgery. We found
that 17.1% of the patients undergoing CABG had a
code for acute myocardial infarction compared to
2.1% of the patients undergoing non-CABG surgery,
indicating that the coding may overestimate the
occurrence of postoperative myocardial infarction in
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these patients. Furthermore, adverse events occurring
after the patient’s discharge would have been missed.
Re-hospitalization would have generated a new hos-
pital stay in the hospital electronic charting system.
All ICD-10 codes for the adverse event would have
been recorded in the new hospital stay.
Third, the study spanned over one decade and the
practice of perioperative medicine and the profile of the
cardiac surgery population may have changed over time.
However, there was no significant variation over the
years in the occurrence of PPC in our cohort and the
sensitivity analysis adjusting for the year of surgery had
no effect on the association between ITMA and PPC.
Furthermore, the surgical and the anesthesia teams did
not change, cardiopulmonary bypass techniques were
also similar; the respiratory protocol to wean the patient
from the ventilator was unchanged, efforts being made
to extubate the patient as soon as physiological criteria
were met. Finally, this is a single center study and the
generalizability of the result may be limited. ITMA was
introduced as part of a perioperative care protocol to-
gether with minimal systemic opioid administration. The
ICU staff was aware of the chosen analgesia technique
and could be influenced regarding treatment decisions.
Conclusion
The results of this study suggest that improving posto-
perative pain control with a small dose of spinal mor-
phine while minimizing systemic opioid administration
may reduce the incidence of PPCs in patients undergo-
ing elective cardiac surgery. These findings warrant a
multicenter randomized trial to demonstrate the effec-
tiveness of this simple and safe intervention, particularly
in patients at high-risk of PPCs.
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